Pulmonary Disease in a Psychiatric Inpatient Population
NCT ID: NCT01823627
Last Updated: 2018-05-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
46 participants
INTERVENTIONAL
2013-03-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis
Chronic obstructive pulmonary disease (COPD) is underdiagnosed in psychiatric inpatients There is a higher prevalence of COPD in psychiatric inpatients compared to the general population Screening of patients with one respiratory symptom and a smoking history, has the same sensitivity regarding to diagnosis of COPD, as screening all patients with a smoking history
Method:
80 psychiatric inpatients will undergo spirometry with reversibility test and COPD Assessment Test (CATest). Furthermore, patient history regarding respiratory symptoms and smoking will be taken into account.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Depressed Chronic Obstructive Pulmonary Disease Patients
NCT00151372
Prevalence and Effect of Detecting Common Mental Disorders in Long-term Sickness Absence
NCT01989728
Detection and Treatment of Somatic Disease in Patients With Severe Mental Disease
NCT03428308
Natural History of Hopelessness, Suicidality, and Optimism in Psychiatric Inpatients Following Discharge
NCT01599247
Implementation of a Multiple Intervention to Promote Healthy Lifestyles in Patients With Depression
NCT06990035
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Spirometry with reversibility test
Spirometry with reversibility test
Spirometry with reversibility test
Spirometry with reversibility test and CATest questionaire. following will be measured FEV1 L/s FVC L/s FEV1/FVC ration
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Spirometry with reversibility test
Spirometry with reversibility test and CATest questionaire. following will be measured FEV1 L/s FVC L/s FEV1/FVC ration
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admission time over 48 hours
Exclusion Criteria
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Naestved Hospital
OTHER
Psykiatrien Syd
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigator, Nicolai Stig Renstrøm
1.Reservelæge
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicolai Renstrom
Role: PRINCIPAL_INVESTIGATOR
Psykiatrien Syd
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Psyciatrien Syd, Region Zealand
Vordingborg, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SJ-322
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.